A Study to Assess the Effect of ASP1585 on Pharmacokinetics of Atorvastatin in Healthy Volunteers

ASP1585 Pharmacokinetic Interaction Study - Pharmacokinetic Interaction With Atorvastatin -

This study is to assess the effect of ASP1585 on pharmacokinetics of atorvastatin in 2x2 crossover method.

Inclusion Criteria:

• Body weight: =<50.0kg, <80.0kg
• Body mass index: =<17.6, <26.4
• Healthy as judged by investigator or caregiver from subjective and objective symptoms and physical examination data

Exclusion Criteria:

• Attending another clinical trial within 120 days before the study
• Blood donation within 90 days (400ml) or 30 days (200ml) before the study
• Receiving any drugs within 7 days before the study
• History of allergy to drugs
• Having GI disorders
• History or complication of liver diseases
• History or complication of heart disease
• History or complication of respiratory diseases
• History or complication of renal diseases
• History or complication of cerebrovascular diseases